CVS Health (CVS) Tops Q4 EPS by 9c, FY EPS Guidance Misses

CVS Health (NYSE: CVS) reported Q4 EPS of $2.14, $0.09 better than the analyst estimate of $2.05. Revenue for the quarter came in at $54.4 billion versus the consensus estimate of $54.58 billion.

GUIDANCE:

CVS Health sees FY2019 EPS of $6.68-$6.88, versus the consensus of $7.41.

For earnings history and earnings-related data on CVS Health (CVS) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Estee Lauder shares jump as fiscal 2027 profit forecast tops estimates
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance